Despite a sluggish start, the Entero Healthcare Solutions IPO managed to get fully subscribed on the third and final day of subscription. The IPO, open from February 9 to February 13, saw a subscription of 1.53 times on the last day. The Entero Healthcare Solutions IPO allotment status is set to be finalised today.

If you applied for the IPO, here is how you can check the Entero Healthcare IPO allotment status.

Checking IPO Allotment Status on Registrar's Website:

Follow these steps to check the Entero IPO allotment status

1. Visit the registrar's website.
2. Click on "Company Selection" and choose "Entero Healthcare Solutions" from the dropdown menu.
3. Then you can enter your PAN, application number, or Demat.
4. Enter the captcha and click Submit to retrieve the Entero Healthcare IPO allotment status

Checking IPO Allotment Status on BSE:

1. Go to the BSE website.
2. Click on the ‘Equity' section and select "Entero Healthcare Solutions" from the dropdown menu.
3. Enter your application number or PAN.
4. Click on the ‘Search' button.
5. The result will show the number of shares allotted to you.

If all the details are entered correctly and the allotment has been finalised, the Entero Healthcare Solutions IPO allotment status will be visible.

See Also: Small Cap Stock Has Slumped 15% In 5 Days, But Analyst Sees 58% Upside

Entero Healthcare Solutions IPO Subscription Status

According to data from the National Stock Exchange (NSE), the company received bids for 1.09 crore shares against the 71.5 lakh shares on offer. Subscription details reveal that the retail investors’ portion was subscribed 1.33 times, the Non-Institutional Investors (NII) portion at 0.22, and the Qualified Institutional Buyers (QIB) portion at 2.28 times. Additionally, the employee portion saw a subscription of 1.25 times.

Entero Healthcare Solutions IPO Details

The Entero Healthcare Solutions IPO is a book-built issue amounting to ₹1,600.00 crores, comprising a fresh issue of 0.79 crore shares valued at ₹1,000.00 crores and an offer for sale of 0.48 crore shares worth ₹600.00 crores. The selling shareholders include Prabhat Agrawal, Prem Sethi, and OrbiMed Asia III Mauritius Limited.

Established in 2018, Entero Healthcare Solutions Limited functions as a distributor of healthcare products across India, catering to hospitals, clinics, and pharmacies. Offering a diverse range of over 4,500 products, the company ensures real-time inventory management and provides services for order fulfilment and claim settlement.

Entero Healthcare Solutions IPO GMP

The Entero Healthcare Solutions IPO GMP is reported at around ₹2. It is a steep drop from the ₹65 reported earlier on February 9, when the IPO opened. It’s important to note that while IPO GMPs can offer a glimpse into market sentiment regarding an IPO, they shouldn’t be the sole determinant of the stock’s performance upon listing.

Read Next: Railway Stocks Continue To Bleed, But Analyst Suggests Holding These 2 Stocks